findmyKOL

Charles Prince, MD

Basic profile

University of Louisville

ORCIDNone on fileNPI
RegionLouisville, KY · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2003Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Charles Prince is a Cardiology physician affiliated with University of Louisville. OpenAlex indexes 20 publications with 1,166 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
20publications

Distinct works indexed by OpenAlex.

1,166citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
21companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1900 Bluegrass Ave
Suite 103
Louisville, KY 402151144

Telephone

502-367-4500

Registry record last updated 8 Mar 2018.

View the NPPES registry record

Industry payments

21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    72.8%
    Beta blocker22.9%
    Metoprolol Succinate47%Carvedilol23%Metoprolol Tartrate19%Sotalol7%Atenolol4%
    Part D<11 patients
    Angiotensin receptor-neprilysin inhibitor (ARNI)7.6%
    Entresto100%
    Part D33 patients

    + 13 more classes in this area

  • Blood & clotting

    19.4%
    Factor Xa inhibitor10.4%
    Eliquis93%Xarelto7%
    Part D<11 patients
    P2Y12 inhibitor8%
    Prasugrel Hcl36%Brilinta35%Clopidogrel29%
    Part D16 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    7.2%
    SGLT2 inhibitor3.5%
    Farxiga100%
    Part D14 patients
    Potassium supplement3%
    Potassium Chloride100%
    Part D11 patients

    + 1 more class in this area

Where care is delivered (Part B)65.8% facility · 34.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”